Compare AU

Compare IBAL vs. DRUG

Compare shares and ETFs on the ASX that you can trade on Pearler.

iShares Balanced Esg ETF

ASX

Buy

Buy

Overview
Industry & Region

Industry & Region


Country Exposure

IBAL

DRUG

United States

47.38 %

71.71 %

Australia

36.02 %

Japan

3.94 %

3.72 %

United Kingdom of Great Britain and Northern Ireland

2.12 %

5.41 %

Canada

1.70 %

Switzerland

1.58 %

8.14 %

France

1.39 %

2.94 %

Netherlands

1.07 %

0.33 %

Denmark

0.91 %

6.30 %

New Zealand

0.89 %

Germany

0.68 %

0.47 %

Sweden

0.55 %

Italy

0.39 %

Spain

0.26 %

Finland

0.23 %

Hong Kong

0.21 %

Singapore

0.21 %

Brazil

0.17 %

Norway

0.10 %

Ireland

0.10 %

Belgium

0.07 %

0.27 %

Portugal

0.01 %

Austria

0.01 %

Israel

0.01 %

Korea

0.35 %

China

0.35 %


Industry Exposure

icon for key differences panel

Key differences

  • IBAL has a higher allocation (99.97 %) in the Other sector than DRUG (75.53 %).

  • The most popular industries that IBAL is exposed to are Other (99.97 %), and Communication Services (0.03 %). Comparatively, DRUG is most exposed to Other (75.53 %), Communication Services (33.53 %), and Health Care (24.47 %).

IBAL

DRUG

Other

99.97 %

75.53 %

Communication Services

0.03 %

33.53 %

Health Care

24.47 %

Consumer Staples

0.14 %

Industrials

0.10 %

Information Technology

0.00 %

Home